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Abstract: The translocator protein (TSPO) is a transmembrane protein present across the three
domains of life. Its functional quaternary structure consists of one or more subunits. In mice,
the dimer-to-monomer equilibrium is shifted in vitro towards the monomer by adding cholesterol,
a natural component of mammalian membranes. Here, we present a coarse-grained molecular
dynamics study on the mouse protein in the presence of a physiological content and of an excess of
cholesterol. The latter turns out to weaken the interfaces of the dimer by clusterizing mostly at the
inter-monomeric space and pushing the contact residues apart. It also increases the compactness and
the rigidity of the monomer. These two factors might play a role for the experimentally observed
incremented stability of the monomeric form with increased content of cholesterol. Comparison with
simulations on bacterial proteins suggests that the effect of cholesterol is much less pronounced for
the latter than for the mouse protein.
Keywords: TSPO; Martini force-field; cholesterol
1. Introduction
The translocator protein (TSPO), also known as peripheral benzodiazepine receptor, is a membrane
protein conserved across the three domains of life [1]. During evolution, the TSPO gene family in
bacteria and plants has expanded its roles [2] from an environmental sensor (such as sensitivity to salt
stress in cyanobacteria and plants [3]) to a functional bioregulator, for instance facilitating the switch
between photosynthesis and respiration, porphyrin transport and regulation of photosynthetic genes
in the Rhodobacter (Rs) bacterium [4].
Mammalian TSPOs are mostly expressed in the outer mitochondrial membrane (OMM) [5].
Their functions may be rather diverse. For instance, in humans, the protein is involved in apoptosis,
autophagy, inflammation along with cholesterol and porphyrin transport [6]. The latter is reminiscent
of bacterial TSPO functions [7]. Human TSPO has emerged as an important neuropharmaceutical
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target. Indeed, TSPO levels are upregulated in activated glial cells, especially in microglia during
neural disorders or injury [8]. As a result, radioligands binding to human TSPO in positron emission
tomography (PET) scan may be used to diagnose CNS disorders [7].
TSPO consists of one or more units of about 18 KDa molecular weight. The topology of each unit,
conserved across bacteria and mammals, consists of five transmembrane helices. These are tightly
packed together (TM1–TM5) and connected by loops, located (for mammals) in the cytoplasm (LP-I
and LP-III) and in the intermembrane space (LP-II and LP-IV) [7]. Structural information on TSPO is
available from the bacteria Bacillus Cereus (Bc) and Rhodobacter sphaeroides (Rs), as well as from mice.
No monomer unit has been observed for Rhodobacter sphaeroides dimer (RsTSPO), neither in vitro
nor in vivo [9]. In the RsTSPO X-ray structure, the protein is present as a dimer [9], suggesting that
the latter is the minimum functional unit of the protein [10]. The X-ray structure of the protein from
Bacillus Cereus (Bc) has also been solved as a dimer [11], although crystal packing forces might have
affected the oligomerization state [12]. In mouse TSPO, multimers (up to six units) exist in vivo [13,14]
and these different oligomeric states may be associated with different functions [6,15]. The structure of
the mouse monomer in the presence of detergent micelles has been solved by solution NMR [16].
Cholesterol represents 10% of OMM [17]. In addition, OMM contains phosphatidylcholine
(PC, 40%), phosphatidylethanolamine (PE, 38.9%), phosphatidylserine (PS, 14.2%), phosphatidylinositol
(PI, 5.9%) and cardiolipin (CDL) 0.8% [17]. Cholesterol has high (nanomolar) affinity for mouse TSPO [18]
and it affects mouse TSPO oligomeric state. It stabilizes in vitro the monomer against the dimer [19],
possibly by binding to a conserved “cholesterol-recognition motif” of the protein [18]. This is referred to
as “LAF-CARC”. CARC is defined by the linear array of residues (L/V)-X1−5-(Y)-X1−5-(K/R), located in
the outer membrane leaflet and its reverse sequence, CRAC, (K/R)-X1−5-(Y/F)-X1−5-(L/V) in the inner
one [20,21]. LAF (Leu-Ala-Phe) is a cholesterol binding enhancement motif associated with CRAC
located one helix turn above the CRAC domain in mammalian TSPO [22]. Cholesterol is instead absent
in the bacterial membrane, and it binds to the bacterial proteins only in the micromolar range [10].
However, bacteria and archaea have a similar CRAC sequence with the central Y replaced by F, probably
to adapt Hopanoids, which have a ring structure similar to that of cholesterol, have been identified in
bacteria as serving a function analogous to that of cholesterol in the higher animals [23]. In RsTSPO
cell membrane, four major classes of phospholipids are present, namely, PE, PC, phosphatidylglycerol
(PGL), and CDL, in a ratio of approximately 5:2:2.4:0.6 (PE/PC/PGL/CDL) [24]. In Bacillus cereus dimer
(BcTSPO), the major lipids that form the membrane are PE 43%, PGL 40% and CDL 17% [25].
Here, we investigate mouse and bacterial TSPOs embedded in membranes with different content of
cholesterol by using coarse-grained molecular dynamics (MD) simulations based on the Martini force
field (version 2.2) [26]. Martini is a widely used coarse-grained force field. Here, several atoms are
grouped together in a “virtual” bead that interact through an effective potential [27]. The simulations
are performed on mouse TSPO monomer and mouse TSPO dimers along with RsTSPO and BcTSPO
dimers, embedded in a membrane resembling the composition of their respective realistic environment
(OMM, Rs bacterial membrane (Rs_mem) and Bc bacterial membrane (Bc_mem) for mouse TSPO,
RsTSPO and BcTSPO, respectively, see Table S1). Comparison is then made with models embedded in
model membranes with physiological cholesterol content (10%, OMM), high cholesterol (28%, chl_mem)
and without cholesterol (Bc_mem and Rs_mem) (Table S1).
The calculations on the bacterial proteins are based on the corresponding X-ray structures of
the dimer [9,11]. Those on mouse TSPO are based on two models of the dimer built by us (available
at [28]), based on RsTSPO dimer X-ray and mouse TSPO monomer NMR structures (see Scheme 1).
The first was fairly consistent with experimental data concerning the dimeric interface [19]; the second
showed larger discrepancies with experiments. Both models were refined here in an OMM-mimicking
membrane by molecular simulation. Notably, the resulting structures were both able to reproduce the
experimental dimer interface showing the impact of the membrane environment on structural models
of membrane proteins. Models of the mouse proteins, embedded in Dodecylphosphocholine (DPC) [29]
and 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC)/cholesterol mixtures [30], have been recently
Molecules 2020, 25, 4299 3 of 18
reported. Anticipating our results, our simulations suggest that cholesterol may stabilize the monomer
by reducing the local and the global fluctuation of the protein; while it might destabilize the dimer by
clusterizing at the subunit–subunit interface and push apart the contact residues. The impact of the
molecule on the bacterial protein dimers appears to be much less evident.
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Scheme 1. Topology of the NMR mouse translocator protein (TSPO) monomer (mTSPO_mon) (A)
and of the monomeric mouse TSPO model based on Rhodobacter sphaeroides dimer (RsTSPO) structure
(mTSPO(Rs)_mon) (B).
2. Results
2.1. TSPO Mouse Dimers
Our previous work presented two models of the protein with and without the nanomolar inhibitor
PK-11195 [28]. These models were based on the RsTSPO dimer X-ray structure (PDB accession code
4UC1) and on the NMR mouse TSPO monomer structure (PDB accession code 2MGY), in complex
with PK-11195 [9,16]. The first, which we call here mTSPO(Rs), was obtained by homology modeling
on RsTSPO dimer; the second, mTSPO, was obtained by duplicating the monomeric mouse TSPO
NMR structure and guiding the building of the dimer on the experimental chemical shifts in [19].
The proteins without ligands underwent refinement here in two different membrane environments
(see Table S1). As shown in the next two sections, the resulting models are consistent with most of the
available experimental data, which concern the dimer interface (i.e., the ensemble of contact residues
across the two monomers) [19].
2.1.1. Models Refinement
In our previous structural prediction of mTSPO(Rs) [28], the G83XXXG87 and the W95XPXF99
dimerization motif were located at the dimer interface, consistently with the experimental data [19].
The monomer–monomer interface turned out to involve V80, G83, W93, I98, and A102 from TM-III and
D111, V118 from TM-IV, consistently with NMR data [19] (Table 1). However, a few residues—known to
be part of the interface—were not sufficiently close to it, even though they were localized near to it [28].
The protein exhibited an electrostatic profile favorable for membrane embedding (Figure 1A) [28].
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Table 1. Residues of mouse TSPO located at the dimer interface identified experimentally [19] (left),
predicted by mTSPO (center) and mTSPO(Rs) structures at the end of the dynamics.
Region Inferred byExperiment mTSPO mTSPO(Rs)
Dimer
interface





F74, T75, E76, D77, M79, V80, P81, G83,
L84, T86, G87, Q88, A90, L91
V6, P7, G10, L11, L13, V14, L17, G18,
F20, M21, Y24 V26, R27, M79, V80,
L82, G83, L84, Y85, T86, G87, A90,
L91, W93, A94, P97, I98, A102, Q104,
W107, A108, A110, D111, L114, V118,
A121, A125
Structures after equilibration in outer mitochondrial membrane (OMM)
M1, P2, S4, W5, P7, A8, G10, L11, T12,
L13, V14, P15, L17, G18, M21, G22, F25,
V26, E29, Y34, L37, K39, P40, R46, V67,
W68, E70, L71, D77, A78, M79, V80, P81,
L82, G83, Y85, T86, G87, Q88, L89, A90,
L91, N92, W93, A94, W95, P96, P97, I98,
F99, F100, G101, A102, R103, Q104, M105,
G106, W107, A108, L109, A110, D111,
L113, L114, V115, S116, G117, V118, A121,
T122, L124, A125, W126, R128, V129, S130,
P131, N151, R166, L167, A168, E169
S4, V6, P7, V9, G10, L11, T12, L13, V14,
P15, L17, G18, F20, M21, G22, Y24,
F25, V26, R27, G28, E29, G30, L31, R32,
W33, W47, W53, Y57, M60, S64, Y65,
V67, W68, K69, E70, L71, G72, G73,
F74, T75, E76, A78, M79, V80, P81,
L82, G83, L84, Y85, T86, G87, L89,
A90, L91, W93, A94, W95, P96, P97,
I98, F100, G101, R103, Q104, M105,
G106, W107, A110, D111, L114, V118,
A121, W126
Residues at the interface according to both experiment and simulations are in red and bold.Molecule  2020, 25, x 4 of 18 
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Figure 1. Electrostatic surface potential of the initial [28] and final molecular dynamics (MD) structures
of (A) dimeric mouse TSPO model based on RsTSPO dimer (mTSPO(Rs)) and (B) dimeric mouse TSPO
model based on NMR structure (mTSPO), in the different m mbra e nvironments simulated here.
The initial structure is the one prior to the embedding in the model membranes and it is the first structure
of each raw image. The shadow behind the second and the third structures of each column indicate the
approximate location of the membrane. The upper part “insert” in B indicates how the exposed polar
side-chains in mTSPO twist tow rd the bulk of the protein after the equilibration. The green arrows
indicate the a ove-mentioned residues in the protein surf ce. The MD structures were backmapped to
all-atom resolution using the backward.py script [31]. The red and blue surfaces represent negative and
positive electrostatic potentials, respectively. The maximum values of the potentials are −5 kT/e and
+5kT/e, respectively (where k is Boltzmann constant, T is the temperature and e is the electric charge of
an electron).
Molecules 2020, 25, 4299 5 of 18
Here, we refined the models by embedding the systems in both OMM and chl_mem and
performing 8 µs MD with the Martini 2.2 coarse-grained force field [26] (see methods). The chosen
model membranes feature physiological (10% of total phospholipids—OMM) and high (28%—chl_mem)
cholesterol content (see Table S1 for composition). After ~1 µs, the structure was equilibrated as
shown by the Root Mean Square Deviation (RMSD) (Figure S1). The RMSD between the initial and
final structure was not very high (4 Å in the TM region), suggesting significant but not very large
displacement from the initial position. The structure at the end of the dynamics displayed a compact
dimer–dimer interface involving a higher number of residues than the starting structure. These include
V80, G83, W93, W95, I98, F100, G101 from TM-III and D111, V118 from TM-IV, reported to be at the
interface, accordingly to the NMR data [19] (Table 1).
The mTSPO starting model, built in [28], did not reproduce several of the experimental data:
indeed, the residues experimentally identified at the monomer–monomer interface, were separated by
a distance of 9 Å or more (N92, W93, W95, I98, F100, G101, and A102, Table 1) [28]; in addition, several
charged residues were exposed in the transmembrane region, not allowing for a favorable embedding
in the membrane [28]. Here, the refinement by MD leads large conformational rearrangements:
the helices tend to twist to bury the exposed polar residues toward the core of the bundle (Figure 1B),
while in parallel, the two monomers tend to get closer to each other to maximize the contact between
residues at the interface (Table 1). Helices one, three and five significantly bend in the intermembrane
region of the receptor (Figure 2A,C,E).
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Figure 2. Porcupine plots depicting prominent motions averaged across the first normal mode for (A) 
mTSPO, (B) mTSPO(Rs) embedded in OMM and cholesterol rich membrane (chl_mem); the 
corresponding plots for the second normal mode are reported in Figure S4. A dotted line marks the 
Figure 2. Porcupine plots depicting prominent motions averaged across the first normal mode
for (A) mTSPO, (B) mTSPO(Rs) embedded in OMM and cholesterol rich membrane (chl_ em);
the corresponding plots for the second normal mode are reported in Figure S4. dotted line marks the
approximate location of the membrane. The helix bending of (C) mTSPO, (D) mTSPO(Rs) in OMM
and chl_mem is plotted as a function of the simulation time. The corresponding helix “hinge” regions
are also shown on mTSPO (E) and mTSPO(Rs) (F) structures in OMM and chl_mem: the highly bent
regions are highlighted in red color, while the least and moderately bent regions are highlighted in blue
and green colors, respectively.
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The structures were equilibrated after ~1 µs and ~2 µs in OMM and in chl_mem, respectively,
as shown by the plot of RMSDs as a function of the simulated time (Figure S1). Notably, the MD structures
at the end of the dynamics showed similar monomer–monomer interface’s features as mTSPO(Rs)
equilibrated structure (Table 1) and a favourable electrostatic profile for membrane embedding.
2.1.2. Structural Properties of the Models
We present here the differences in structure and conformational fluctuations of mTSPO and
mTSPO(Rs) dimers during the equilibrated trajectory, namely for the last 6 µs.
The RMSDs (Figure S1 and Table 2), the Root Mean Square Fluctuations (RMSFs) (Figures S2A,B
and S3) and the gyration radii (Figure S2C,D and Table 2) of the two models do not vary significantly
by changing membrane environment (Figures S1 and S2). High flexibility regions are observed for the
loops and the termini, as expected (Figure S2).
Table 2. Root mean square deviation (RMSD) and radii of gyration values of the systems investigated
here, averaged over the equilibrated trajectories (namely the last 6 µs for mouse monomeric and dimeric
systems and 1.3 µs for the bacterial systems).
System RMSD (nm) Radius of Gyration (nm)
mTSPO_mon, OMM 1.2 ± 0.05 1.7 ± 0.03
mTSPO_mon, chl_mem 0.6 ± 0.05 1.8 ± 0.03
mTSPO(Rs)_mon, OMM 0.8 ± 0.05 1.7 ± 0.02
mTSPO(Rs)_mon, chl_mem 0.6 ± 0.05 1.7 ± 0.02
mTSPO, chain A, OMM 1.1 ± 0.05 1.7 ± 0.02
mTSPO, chain B, OMM 1.0 ± 0.05 1.8 ± 0.02
mTSPO, chain A, chl_mem 1.2 ± 0.04 1.7 ± 0.01
mTSPO, chain B, chl_mem 1.1 ± 0.06 1.8 ± 0.02
mTSPO(Rs), chain A, OMM 0.8 ± 0.05 1.8 ± 0.02
mTSPO(Rs), chain B, OMM 0.6 ± 0.05 1.7 ± 0.01
mTSPO(Rs), chain A, chl_mem 0.6 ± 0.04 1.7 ± 0.02
mTSPO(Rs), chain B, chl_mem 0.5 ± 0.05 1.7 ± 0.01
BcTSPO, chain A, Bc_mem 0.6 ± 0.01 1.6 ± 0.01
BcTSPO, chain B, Bc_mem 0.6 ± 0.02 1.6 ± 0.01
BcTSPO, chain A, chl_mem 0.5 ± 0.03 1.6 ± 0.01
BcTSPO, chain B, chl_mem 0.6 ± 0.02 1.6 ± 0.01
RsTSPO, chain A, Rs_mem 0.7 ± 0.04 1.7 ± 0.01
RsTSPO, chain B, Rs_mem 0.5 ± 0.02 1.7 ± 0.01
RsTSPO_chain A, chl_mem 0.6 ± 0.04 1.7 ± 0.01
RsTSPO_chain B, chl_mem 0.6 ± 0.03 1.7 ± 0.02
A principal component analysis (PCA) was used to identify differences in large scale motions of
the proteins (Figure S3). We represent the first two eigenvectors (which cover between 31% and 38%
of the motions of the proteins) as porcupine plots to show the direction and magnitude of selected
eigenvectors for each of the backbone beads. mTSPO’s conformational flexibility was larger than that
of mTSPO(Rs) in OMM (Figure 2A), as can be seen by the porcupine plots of the first and second
eigenvector (Figure S4). The flexibilities were similar for the two proteins embedded in chl_mem
(Figure 2 and Figure S4), however, at the dimer interface of both dimers, the two first eigenvectors
“push” the residues far apart, hinting toward a destabilization of the dimers’ interface (Figure 2 and
Figure S4). Helix conformational changes were calculated using the “Bendix” software v.1.1 [32].
This software uses a sliding window of four residues to give local helix axes that are joined by a
spline. Analysis is performed on this axis to give local angles along the length of the helix versus time.
The helix distortion distribution is visualized across residues by heatmap color-coding according to
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local angle magnitude, which highlights nonlinear behaviour of the alpha helix axes. We noticed that
in mTSPO(Rs), the axes of the helices are mostly linear, while in mTSPO, TM1, TM3 and TM5 are bent
in the lower part corresponding to the mitochondria side (Figure 2C,E) in both OMM and chl_mem.
The latter behaviour highlights the main difference in the geometry of the helix bundle on passing from
mTSPO to mTSPO(Rs). The number of contacts at the dimer interface decreases in chl_mem (Figure 3).
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2.2. Mouse TSPO Monomers
2.2.1. Models Refinement
We predicted here the monomer structures based on the RsTSPO structure [9] (mTSPO(Rs)_mon
hereafter) and the NMR structure of monomeric mouse TSPO [16] (mTSPO_mon). The electrostatic
surface of mTSPO(Rs)_mon starting model was favorable to membrane embedding, while this was not
the case for mTSPO_mon [28], similarly to what observed for the initial structures of the corresponding
dimers. The proteins were embedded in OMM and in chl_mem. They underwent 8 µs MD with the
Martini coarse-grained force field version 2.2 [26], as in the case of the dimers.
mTSPO(Rs)_mon turned out to be equilibrated after about 1 µs, as shown by the plot of the
RMSD as a function of simulated time (Figure 4). The electrostatic surface of the protein already
showed a favorable distribution of apolar/polar residues for membrane embedding (Figure 5A). Further
optimization of side chain distribution can be observed after equilibration (Figure 5A).
Molecules 2020, 25, 4299 8 of 18
Molecules 2020, 25, x 8 of 18 
 
showed a favorable distribution of apolar/polar residues for membrane embedding (Figure 5A). 
Further optimization of side chain distribution can be observed after equilibration (Figure 5A). 
 
Figure 4. Backbone beads RMSD of (A) mTSPO_mon and (B) mTSPO(Rs)_mon (whole protein and 
TM regions) embedded in OMM and chl_mem plotted as a function of the simulated time. The RMSDs 
are computed with respect to the initial structures. 
mTSPO_mon required instead 2 μs to be equilibrated (Figure 4). It indeed underwent several 
conformational rearrangements similarly to what happened for the corresponding dimer. As a result, 
the protein becomes more compact. In addition, the electrostatic surface of the TM region in the 
equilibrated structures exposed more hydrophobic residues with respect to the initial structure. This 
rendered the protein compatible with the embedding in the membrane environment (Figure 5B), in 
contrast to the initial NMR structure [28]. 
 
Figure 5. Electrostatic surface potential of the initial and equilibrated conformations, extracted from 
the trajectories after convergence (7.5 μs) and backmapped to all-atom resolution with the amber force 
field [33] using backward.py [31] of mTSPO(Rs)_mon (A) and mTSPO_mon (B) embedded in OMM 
i r s R SD of (A) mTSPO_mon and (B) mTSPO(Rs)_mon (whole protein a d TM
regions) embedd in OMM and chl_mem plotted as a function of the simulated ime. The RMSDs are
computed with resp ct to the initial structures.
Molecules 2020, 25, x 8 of 18 
 
showed a favorable distribution of apolar/polar residues for membrane embedding (Figure 5A). 
Further optimization of side chain distribution can be observed after equilibration (Figure 5A). 
 
Figure 4. Backbone beads RMSD of (A) mTSPO_mon and (B) mTSPO(Rs)_mon (whole protein and 
TM regions) embedded in OMM and chl_mem plotted as a function of the simulated time. The RMSDs 
are computed with respect to the initial structures. 
mTSPO_mon required instead 2 μs to be equilibrated (Figure 4). It indeed underwent several 
conformational rearrangements similarly to what happened for the corresponding dimer. As a result, 
the protein becomes more compact. In addition, the electrostatic surface of the TM region in the 
equilibrated structures exposed more hydrophobic residues with respect to the initial structure. This 
rendered the protein compatible with the embedding in the membrane environment (Figure 5B), in 
contrast to the initial NMR structure [28]. 
 
Figure 5. Electrostatic surface potential of the initial and equilibrated conformations, extracted from 
the trajectories after convergence (7.5 μs) and backmapped to all-atom resolution with the amber force 
field [33] using backward.py [31] of mTSPO(Rs)_mon (A) and mTSPO_mon (B) embedded in OMM 
Figure 5. Electrostatic surface potential of the initial and equilibrated conformations, extracted from
the trajectories after convergence (7.5 µs) and backmapped to all-atom resolution with the amber force
field [33] using backward.py [31] of mTSPO(Rs)_mon (A) and mTSPO_mon (B) embedded in OM
and chl_mem. Red and blue surfaces represent negative and positive electrostatic potentials (−5 kT/e,
+5kT/e) respectively.
mTSPO_mon required instead 2 µs to be equilibrated (Figure 4). It indeed underwent several
conformational rearrangements similarly to what happened for the corresponding dimer. As a
result, the protein becomes more compact. In addition, the electrostatic surface of the TM region in
the equilibrated structures exposed more hydrophobic residues with respect to the initial structure.
This rendered the protein compatible with the embedding in the membrane environment (Figure 5B),
in contrast to the initial NMR structure [28].
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2.2.2. Structural Features
Here we present the differences in structure and conformational fluctuations of mTSPO_mon and
mTSPO(Rs)_mon during the equilibrated trajectory, namely for the last 6 µs.
The two models differ significantly: mTSPO_mon features a kink in helix five (Figure 6A), while
mTSPO(Rs)_mon has a kink in helix one (Figure 6B). The averaged backbone beads RMSDs decrease in
all circumstances with cholesterol content (Figure 4 and Table 2). Instead, the radii of gyration are rather
similar (Figure S5). The averaged RMSF values decrease in correspondence with the transmembrane
regions (TM1: 7–26, TM2: 46–63, TM3: 82–101, TM4: 106–124 and TM5: 134–153 for mTSPO and
TM1: 8–23, TM2: 48–62, TM3: 83–98, TM4: 107–123 and TM5: 136–152 for mTSPO(Rs)) on passing
from the systems embedded in OMM to chl_mem (Figure S6). High flexibility regions are observed in
the loops and terminal regions, as expected (see Figure S6). The region 125–140 was more flexible in
mTSPO_mon than in mTSPO(Rs)_mon, which harbors the cholesterol-binding motif [19].
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Figure 6. The helix bending of (A) mTSPO_mon and (B) mTSPO(Rs)_mon embedded in both OMM
and chl_mem as a function of the simulation time. Only the last 6 µs are shown. The corresponding
helix “hinge” regions are also shown o mTSPO_mon (C) and mTSPO(Rs)_mon (D) structures in OMM
and chl_mem: the highly bent regions are hi hlighted in red color, while the least and moderat ly be t
regions are highlighted in blue and re n colors, respectively.
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The first three eigenvectors in the PCA occupy between 35.8% and 50.4% of the conformational
space of the proteins (Figure S7). They are larger for the proteins embedded in OMM than those
embedded in the chl_mem (Figure 7 and Figure S8). Therefore, we suggest that the binding of
cholesterol reduces the conformational fluctuations of the proteins.
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Figure 7. Porcupine plots depicting prominent motions averaged across the first normal mode for
(A) mTSPO_mon and for (B) mTSPO(Rs)_mon, in both OMM and chl_mem. A dotted line marks the
approximate location of the membrane. Longer spines indicate the region with higher fluctuations for
the first normal mode. These correspond to the cytoplasmic loops. The analysis was performed on the
equilibrated part of the trajectory. The second normal mode is reported in Figure S8.
2.3. Cholesterol Occupancy
Given the significant effects of cholesterol described above, to conclude, we analyzed the occupancy
of cholesterol molecules in the two different membrane environments, for both monomer and dimer
mouse TSPO models. In an overabundance of cholesterol (that is, for the proteins embedded in
chl_mem), cholesterol molecules are spread rather homogeneously around the TM regions (Figure 8).
This is fully consistent with the coarse-grained dynamics simulation study by Rao et al. [30] on the same
protein, performed in a DMPC/cholesterol mixture. These authors found that “cholesterol molecules
are spread homogeneously in the membrane despite the presence of dimers” [30]. In contrast, for
the proteins embedded in a membrane with physiological content of cholesterol (OMM), cholesterol
clusters at TM1, TM3 and TM4 located at the dimer interface (Figure 8), and, for the mTSPO_mon, also
at TM5. This helix contains the two well-known cholesterol-binding motifs, CRAC (residues 149–156)
and its reverse counterpart CARC (residues 135–146) [20,21].
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Figure 8. Cholesterol occupancy (i.e., percentage of frames where the lipid is in contact with a given
residue (0–100%)) for (A) mTSPO, mTSPO_mon and (B) mTSPO(Rs), mTSPO(Rs)_mon in both OMM
and chl_mem. The analysis was performed on the equilibrated part of the trajectory, that is, the last 6 µs.
Labeling of the helices is done only on the top view of each system for clarity. (C) Selected snapshots
from our simulations illustrating cholesterol position at the protein surface for mTSPO, mTSPO_mon,
mTSPO(Rs) and mTSPO(Rs)_mon in OMM membrane.
2.4. Bacterial TSPO Dimers
BcTSPO and RsTSPO embedded in the Bc_mem and Rs_mem (without cholesterol, as in natural
bacterial membranes [25,34] respectively, and chl_mem (with 28% cholesterol) (Table S1) underwent
2 µs coarse-grained MD simulations. As shown by the RMSD plot as a function of simulated ime
(Figu e S9), the systems reached equilibrium already after 700 ns, p ssibly because in this case we
started f om X-ray structures and ot theoretical models. The average displacement from th initial
structures wer ~0.6 nm for both str ctures (Figure S9).
The RMSD, RMSF and gyration radius (Figures S9–S11) s well as the alculated electrostatic
urfaces along the simulation (Figure S12) were similar across the four systems investigated here.
Additionally, the bending of the helices oes not change on p sing from the bacterial m mbranes
to chl_mem (Figure S15). The contacts at the interface of the proteins embedded in Bc_mem and
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Rs_mem are larger than those in chl_mem (Figure S13). In our PCA analysis (Figure S14), the first two
eigenvectors exhibit very small fluctuations at the interface in both membranes (Figure 9). Based on all of
these observations, we conclude that the presence of cholesterol impacts on the structural determinants
and conformational fluctuations of the proteins to a lesser extent than in the mouse proteins.
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Figure 9. Porcupine plots depicting prominent motions averaged across the first normal mode for:
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line marks the approximate location of the membrane. Longer spines indicate the region with higher
fluctuations for the first normal mode. These correspond to the periplasm loops. The analysis was
performed on the equilibrated part of the trajectory, namely the last 1.3 µs.
3. Discussion
Cholesterol is an essential component of mammalian membranes [35]. Among the TSPO functions
gained during speci tion and evolution leading to ma m ls, is the bi ding and trafficking of this
molecule [1]. R cent work by J ipura et al. has shown that cholesterol stabilizes the monomeric against
the dimeric state in mouse TSPO [19]. Here, we present a coarse-grained MD study on these proteins
embedded in embranes at different cholesterol contents to attain an insi ht on this intriguing eff ct
of this molecule. Comparison is made with bacterial proteins, sugg sted to exist in dimeric form and
binding with much less affinity cholesterol than mouse TSPO.
Dimer and mo omer models, built by us in [28] and refined here by coarse-grained MD,
were emb dde in tw types f membranes: (i) OMM, which contains six different types of lipids and
aroun 10% of cholesterol. This provides a quasi in-vivo mimetic membrane environment; (ii) chl_mem,
with a high ch lesterol content (28% instead of 10%).
The dimeric models were fully consistent with the experimental data, which are available only
for this state [19] (Table 1). Besides, ur model based on the ouse NMR monomer structure [16],
exhibits a similar interface to that of a recent imeric m del presented [30] involving TM1 and TM3
helices. The electrostatic potential surfaces of dimer and monomer i itial models based on Rs bacterial
structure is suitable for embedding in the cell membrane. This contrasts with the mouse monomeric
NMR struct re [16] (used here as a starting model for so e of our simulations). The electrostatic
potential surface is favorable for membrane embedding only after equilibrati n of the protein in a
realistic membrane environment. This supp rts the hypothesis that the ionic detergents used in t e
structure determination experiment may have altered s me key structural features relevant for the
stability of the protein in a membrane environment [12,29].
Both the simulations of the monomers and the dimers hi t a stabilization of the latter by adding
cholesterol. First, at the physiological content of cholesterol, this is located mostly at residues at
the dimeric interface, while in mTSPO_mon, cholesterol is found at the two cholesterol-binding
motifs, CRAC and CARC [20,21]; second, an overabundance of cholesterol causes a ecrease in
subunit–subunit contacts in the dimer: consistently, the large-scale motions might favor a detachment
of the two units by pushing apart the residues in contact at the interface, as shown by our PCA
analyses. All these features point to a estabilizing effect of cholesterol on the dimeric structure. Finally,
under the reasonable assumption that the compactness and rigidity of proteins may correlate with
thermodynamic stability [36], one can suggest that cholesterol stabilizes the monomer. Indeed, (i) the
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size of the monomeric mouse TSPO models, in terms of RMSD and gyration radii, decreases with
cholesterol content, in contrast to what happens in the dimeric forms; (ii) the fluctuations, as measured
by RSMF values, are lower; (iii) the large-scale motions exhibit a smaller amplitude in the presence of
cholesterol for both the monomeric proteins.
Cholesterol affects to a lower extent the size and rigidity of the corresponding bacterial proteins.
These are naturally embedded in a cholesterol-free membrane and present most probably as dimers [9].
Indeed, RMSD gyration radii do not vary significantly upon the addition of cholesterol. In addition,
RMSF and large-scale motion are not significantly affected by the presence of this molecule. However,
the contacts at the subunit–subunit interface decrease with an excess of cholesterol (albeit to a smaller
extent than what was observed in the mouse protein). Hence, the study for the bacterial proteins is
not conclusive. This is probably due also to the fact that the CRAC motifs on the bacterial structures
(with the central Y replaced by F) were possibly optimized for Hopanoids, that in bacteria can perform
a function analogous to that of cholesterol in the higher animals [23].
Are cholesterol binding, TSPO oligomerization state and the TSPO involvement in cholesterol
transport or regulation connected among each other? Cholesterol binds to TSPO in vitro and
in vivo [18,19]. However, on one hand, cholesterol molecules were identified in none of the reported
TSPO X-ray or NMR structures [7]; in addition, no evident channel emerges from a structural analysis of
the monomeric or dimeric structures [37]; Finally the dimer interface does not involve any of the residues
defined in the CRAC site or the enhancement motif. On the other hand, experiments in mammalian cell
culture systems provide evidence of a 800-kDa protein-complex driving cholesterol import, trafficking,
and metabolism [15]. In this complex, TSPO is proposed to be the cholesterol binding/sequestering
site, along with StAR, and the voltage-dependent anion channel (VDAC). The latter is proposed to be
the direct binding partner of TSPO that facilitates transport. This has led to the general suggestion that
an “external pathway” allows for cholesterol binding. This pathway is expected to involve a dimer of
dimers and/or other binding partner(s) [7,9]. Identifying the hitherto unknown binding interface of
TSPO with VDAC and possibly other components of the transduceosome and metabolon complexes is
therefore crucial to get further insight on the overall cholesterol transport activity.
4. Materials and Methods
4.1. System Setup of Coarse-Grained Models
The structure of mouse TSPO (mTSPO_mon) was the NMR structure (PDB accession code: 2MGY).
The first conformation was chosen as it corresponds to the best representative conformer in the
ensemble and the ligand PK-11195 was removed. The dimer mTSPO was constructed based on the
NMR study reported in [16]. Another model of mouse TSPO was built by us (mTSPO(Rs)_mon and
mTSPO(Rs) for monomeric and dimeric forms, respectively), by homology modeling, based on the
X-ray coordinates of the prokaryotic RsTSPO (PDB accession code: 4UC1) [9].
The structures of bacterial TSPO were taken from the X-ray structures 4RYI (BcTSPO) [11] and
4UC3 (RsTSPO) [9]. Missing residues of 4UC3 between GLU29 and ASN40 in chains A and B were
modelled using as template the structure 4UC2 [9], while those between MET147 and ARG157 of
chain B were modelled using the same region in chain A of 4UC3 [9]. The Modeller program version
9.19 [38] was used to build the missing regions and the best model according to the Discrete Optimized
Protein Energy (DOPE) [39] and GA341 [40] score was selected. The default protonation states at pH
7 were used for the ionizable residues. Protein structures were converted to coarse-grained Martini
representations using the martinize.py script [26]. The coarse-grained protein coordinates were then
positioned in the center of a simulation box of size 14 × 14 × 16 nm3 with its principal transmembrane
axis aligned parallel to the z-axis and embedded in different symmetric lipid bilayers: (i) chl_mem
contains: phosphatidylcholine (POPC, 31%), phosphatidylethanolamine (POPE, 41%) and cholesterol
(CHOL, 28%). (ii) A realistic mammalian outer mitochondrial membrane (OMM) composed of six
different lipid species [17,41–44]: POPC, 40%, 1-stearoyl-2-docosahexaenoyl-phosphatidylethanolamine
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(SDPE, 38.9%), 1-stearoyl-2-docosahexaenoyl-phosphatidylserine (SDPS, 14.2%), stearoyl-arachidonoyl
phosphatidylinositol (SAPI, 5.9%), doubly deprotonated cardiolipin (CDL2, 0.8%) and CHOL, 10% of
total phospholipids, providing an in vivo-mimetic membrane environment. (iii) Rs_mem composed of
POPC, 20%, POPE, 50%, palmitoyl oleoyl phosphatidylglycerol (POPG, 24%) and cardiolipin (CDL2,
6%) [34] and (iv) Bc_mem containing POPE, 43%, POPG, 40% and CDL2, 17% [25]. NaCl (0.15 M)
was added to reach the physiological ions concentration and extra ions were added to neutralize
the systems.
4.2. Coarse-Grained Simulation Parameters
The Martini coarse-grained force field version 2.2 [26] was used for protein and version 2.0 for
lipids. All the simulations were performed using Gromacs 2019.3 [45]. The non-biased simulations
were run in the isothermal-isobaric NPT ensemble equilibrium simulations. The temperature was
controlled at 315K using V-rescale thermostat [46] with a coupling constant of τt = 1.0 ps. The pressure
was semi-isotropically controlled (i.e., independently in the xy plane and z axis direction) by a
Parrinello–Rahman barostat [47] at a reference of p = 1 bar with a coupling constant of τp = 12.0 ps and
compressibility of 3 × 10−4. Non-bonded interactions were used in their shifted form with electrostatic
interactions shifted to zero in the range of 0–1.1 nm and Lennard-Jones interaction shifted to zero in
the range of 0.9–1.1 nm. A time step of 20 fs was used with neighbor lists updated every 20 steps.
Periodic boundary condition was used in the x, y and z axis. Data (~8 µs and 2 µs) were collected for
mouse TSPO and bacterial TSPO simulations, respectively. An overview of the simulations is listed in
Table S1.
Analysis of molecular dynamics results. The root mean square deviation of backbone beads
(RMSD), the root mean square fluctuations (RMSF) and the radius of gyration (RGYR) were calculated
using gmx rms, rmsf and gyrate modules from the Gromacs package [45], respectively. Principal
component analysis (PCA) was restricted to backbone beads, as it is less perturbed by statistical
noise and provides significant characterization of the essential space motions [48]. It was performed
using Gromacs tools gmx covar and gmx anaeig [45]. To visualize the direction and extent of the
principal motions of the simulated systems, porcupine plot analysis was performed using modevectors
script in Pymol [49]. When applied, for each simulated system, the initial structure was used as a
reference. The helix bundle geometrical features were characterized by implementing the Bendix
plug-in [32] in VMD software [50], that calculates and visualizes the helix axis evolution over time.
It was performed using default parameters for coarse-grained systems. Electrostatic calculations were
performed on the initial structures and the ones after equilibrium. Conformations were first extracted
and backmapped to all-atom resolution in amber force field [33] using backward.py [31]. Electrostatics
were then performed with the APBS Electrostatics plugin in Pymol [51] using default parameters.
The gmx mindist module in Gromacs [45] was used to compute the number of contacts in
time between each monomer in the simulated dimers, using the default distance cutoff of 0.6 nm.
The cholesterol occupancy (i.e., percentage of frames where lipid is in contact with the given residue
(0–100%)) was calculated using the toolkit PyLipID [52] and a distance cutoff of 0.55 and 1.0 nm.
5. Conclusions
We have presented a molecular dynamics study on mouse TSPO monomeric and dimeric structures.
Our models are fully consistent with the available experimental data [19]. In addition, they provide
hints on why cholesterol shifts the monomer–dimer equilibrium toward the monomer in mouse
TSPO. Simulations with the correspondent proteins from Bc and Rs bacteria might suggest that the
destabilization of the dimer by cholesterol (a molecule not present in bacterial membranes) is not as
pronounced as in the case of the mouse proteins.
How the effect of cholesterol on mouse TSPO may affect its function is still unclear. Until recently,
there has been general agreement as to the role of TSPO in steroidogenesis. However, recent studies
involving genetic depletion of TSPO in mice have created controversy about the role of this protein in
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steroid and heme synthesis [53]. The discrepant finding in the literature was attributed to the fact that
mitochondrial functions are a critical component of cellular survival; the presence of redundancy in
mechanisms that mediate crucial mitochondrial functions would be expected [54]. Redundancy in the
mitochondrial carrier system transporting small molecules between mitochondria and the cytoplasm
was indeed already shown and loss of one could be replaced by another gene or genetic network [55].
Up to now, no human has been identified who lacks TSPO. However, the presence of rs6971
polymorphism (A147T) on the TSPO gene can affect the hypothalamic–pituitary–adrenal axis,
predisposing carriers to psychiatric disorders [56]. Therefore, there has been general agreement
on the therapeutic value of TSPO as a target for brain pathologies and potentially in conditions
of hypogonadism. Although TSPO is a 3.5-billion-year-old protein, we still have unsolved issues
concerning its structure, function and pharmacology. Solving these will allow us to better understand
not only the evolution of a protein, but also of related processes, such as steroidogenesis, that are
critical for life.
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Figure S15: Helix bending of BcTSPO and for RsTSPO.
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Abbreviations
mTSPO Dimeric mouse TSPO model based on NMR structure (PDBiD: 2MGY)
mTSPO_mon Monomeric mouse TSPO model based on NMR structure (PDBiD: 2MGY)
mTSPO(Rs) Dimeric mouse TSPO model based on RsTSPO dimer (PDBiD: 4UC1)
mTSPO(Rs)_mon Monomeric mouse TSPO model based on RsTSPO dimer (PDBiD: 4UC1)
RsTSPO Rhodobacter sphaeroides dimer (PDBiD: 4UC3)
BcTSPO Bacillus cereus dimer (PDBiD: 4RYI)
OMM Mammalian Outer Mitochondrial Membrane
Chl_mem Cholesterol rich membrane
Rs_mem Rs bacterial membrane
Bc_mem Bc bacterial membrane
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47. Martoňák, R.; Laio, A.; Parrinello, M. Predicting crystal structures: The Parrinello-Rahman method revisited.
Phys. Rev. Lett. 2003, 90, 075503. [CrossRef]
48. Van Aalten, D.M.; De Groot, B.L.; Findlay, J.B.; Berendsen, H.J.; Amadei, A. A comparison of techniques for
calculating protein essential dynamics. J. Comput. Chem. 1997, 18, 169–181. [CrossRef]
49. DeLano, W.L. The PyMOL Molecular Graphics System; Schrödinger: New York, NY, USA, 2002.
50. Humphrey, W.; Dalke, A.; Schulten, K. VMD: Visual molecular dynamics. J. Mol. Graph. 1996, 14, 33–38.
[CrossRef]
51. Lerner, M.; Carlson, H. APBS Plugin for PyMOL; University of Michigan: Ann Arbor, MI, USA, 2006.
52. Song, W.; Duncan, A.; Corey, R.; Ansell, B. PyLipID. Available online: https://github.com/wlsong/PyLipID
(accessed on 17 September 2020).
53. Zhao, A.H.; Tu, L.N.; Mukai, C.; Sirivelu, M.P.; Pillai, V.V.; Morohaku, K.; Cohen, R.; Selvaraj, V. Mitochondrial
Translocator Protein (TSPO) Function Is Not Essential for Heme Biosynthesis. J. Biol. Chem. 2016, 291, 1591–1603.
[CrossRef]
54. Papadopoulos, V.; Fan, J.; Zirkin, B. Translocator protein (18 kDa): An update on its function in steroidogenesis.
J. Neuroendocrinol. 2017, 30, e12500. [CrossRef]
55. Taylor, E.B. Functional Properties of the Mitochondrial Carrier System. Trends Cell Biol. 2017, 27, 633–644.
[CrossRef]
56. Da Pozzo, E.; Costa, B.; Martini, C. Translocator protein (TSPO) and neurosteroids: Implications in psychiatric
disorders. Curr. Mol. Med. 2012, 12, 426–442. [CrossRef]
Sample Availability: Models of the systems reported are available from the authors.
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
